Audio is streamed directly from the publisher (mcdn.podbean.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Credits: 0.25 AMA PRA Category 1 Credits™, 0.25 ABIM MOC or 0.25 AANP, including 0.25 AANP Pharm
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/novo-glp1-podcast-1
Overview: In this podcast, cardiologist Ty Gluckman will take a deep dive into the cardiology benefits of glucagon like peptide-1 receptor agonists (GLP-1 RA). He will review the clinical trial data which has resulted in GLP-1 RA incorporation into guidelines, which address patients who have both diabetes and atherosclerotic cardiovascular disease. He will present the recent American College of Cardiology guidelines and discuss the perspective of a cardiologist on these agents with emerging significance in cardiovascular risk reduction.
Guest: Ty J. Gluckman, MD, FACC, FAHA